> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Notifying Applicants of Sentinel Analyses MAPP
- URL: https://www.fdaweb.com/notifying-applicants-of-sentinel-analyses-mapp/
- Published: 2020-08-18T12:00:00.000Z
- Updated: 2026-09-14T16:25:20.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5147453

CDER has issued a Manual of Policies and Procedures, *Notifying Applicants of Sentinel Analyses and Results*, describing the policies and procedures followed by the Office of Surveillance and Epidemiology for notifying an applicant or holder of an NDA or BLA about certain types of safety studies conducted in the Sentinel system. The [MAPP](https://www.fda.gov/media/141216/download?ref=fdaweb.com) describes the content, method, and timing of applicants notifications related to the use of Sentinel’s active risk identification and analysis system.